ArticleJournal of nanobiotechnology2022

A novel nanobody-heavy chain antibody against Angiopoietin-like protein 3 reduces plasma lipids and relieves nonalcoholic fatty liver disease.

Xiaozhi Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.